DA Davidson analyst Linda Bolton Weiser lowered the firm’s price target on Usana (USNA) to $35 from $38 and keeps a Neutral rating on the shares after its lower than expected Q3 revenue. Sales performance in the quarter was modestly below the company’s expectations as consumer spending in many of its markets remained under pressure due to macroeconomic factors, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on USNA:
- Closing Bell Movers: Starbucks falls 4% on negative pre-announcement
- USANA Health Faces Q3 2024 Sales Decline Amid Challenges
- Usana reports Q3 EPS 56c, two estimates 48c
- Usana now sees FY24 EPS $2.45, previous view $2.40-$2.55
- USANA Health Sciences Inc (USNA) Q3 Earnings Cheat Sheet
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
